Skip to main content
HVIVO PLC logo

HVIVO PLC — Investor Relations & Filings

Ticker · HVO ISIN · GB00B9275X97 LEI · 213800VT5KBM7JLIV118 IL Professional, scientific and technical activities
Open in API
Filings indexed 758 across all filing types
Latest filing 2025-07-18 Board/Management Inform…
Country GB United Kingdom
Listing IL HVO

About HVIVO PLC

https://hvivo.com/

hVIVO plc is a full-service contract research organization (CRO) and a leading specialist in human challenge trials. The company provides end-to-end clinical development solutions for a global biopharma client base, focusing on infectious and respiratory diseases. Its services span from preclinical consultancy to Phase III clinical trials, including first-in-human studies, biometry, and consulting. hVIVO operates a state-of-the-art quarantine facility in London and provides advanced laboratory services under its hLAB brand. Through subsidiaries such as CRS and Venn Life Sciences, it offers early-phase clinical trial expertise and patient recruitment across multiple clinical sites. The company's integrated approach is designed to accelerate the development of vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
Directorate Change
Board/Management Information Classification · 99% confidence The document is a formal announcement released via RNS (Regulatory Information Service) with the RNS Number 5751R. The core content announces a 'Directorate Change'—specifically, the resignation of Tracey James as a Non-Executive Director. This directly relates to changes in the company's board of directors or senior management. According to the definitions, this corresponds precisely to the Board/Management Information category (MANG). Although it is distributed via RNS, the specific content dictates the MANG classification over the general RNS fallback.
2025-07-18 English
Notice of Trading Update
Regulatory Filings Classification · 98% confidence The document is an official announcement from hVIVO plc, identified by the 'RNS Number' and the header 'RNS Number : 2591Q'. The title is 'Notice of Trading Update'. The core content states that the company 'confirms that it will issue a trading update for the six months ended 30 June 2025 on Tuesday 22 July 2025.' It also announces a related investor presentation. Since this document is an announcement *about* a future report (the trading update) and an associated event (the presentation), and it is distributed via RNS (the news service of the London Stock Exchange), it fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given that it specifically announces the publication date of a financial update, RPA is the most precise fit, as it signals the upcoming release of financial information, rather than being the financial information itself (which would likely be an IR or ER).
2025-07-09 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 2787P" and contains the standard header/footer information associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content details a "TR-1: Standard form for notification of major holdings" regarding an acquisition or disposal of voting rights by Rathbones Investment Management Ltd, crossing a threshold. This type of mandatory disclosure concerning changes in significant share ownership falls directly under the definition of Major Shareholding Notification (MRQ). Although it is an RNS filing, MRQ is a more specific category than the general RNS fallback.
2025-07-01 English
Positive results from client Phase 2b field study
Earnings Release Classification · 99% confidence The document is identified by the RNS Number header and the presence of contact information for financial advisors and brokers, typical of a regulatory news service announcement. The content describes positive topline results from a client's Phase 2b study, which hVIVO supported. This is a press release announcing operational and scientific achievements, not a formal statutory financial filing like a 10-K or an IR. Since it is a general announcement distributed via RNS and does not fit into specific categories like ER (Earnings Release), DIV (Dividend), or CT (Call Transcript), it falls best under the general Regulatory Filings category (RNS) or potentially an Investor Presentation (IP) if it were a slide deck, but given the format and distribution method ('This information is provided by Reach, the non-regulatory press release distribution service of RNS'), RNS is the most appropriate fallback for a general corporate update distributed through this channel. H1 2025
2025-06-30 English
Result of AGM
AGM Information Classification · 99% confidence The document explicitly states it is an announcement regarding the 'Result of AGM' (Annual General Meeting). It confirms that 'all resolutions put to shareholders at the Company's Annual General Meeting ('AGM') held earlier today were duly passed.' It also mentions that the voting results will be published shortly on the company website. This content directly relates to the outcome of a shareholder meeting. The presence of the RNS Number and the closing statement referencing RNS (Regulatory News Service) suggests it is a regulatory announcement. Since the core topic is the result of the AGM, the most specific code is AGM-R (AGM Information). Although it announces the results, which could sometimes lean towards DVA, AGM-R is specifically defined for AGM materials/presentations, and this announcement confirms the outcome of that meeting. Given the context of reporting the outcome of the AGM, AGM-R is the best fit, although DVA (Declaration of Voting Results) is a close secondary possibility. I will select AGM-R as it is directly tied to the AGM event itself.
2025-06-05 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is an RNS announcement from hVIVO PLC, dated June 2, 2025. The core content details the purchase of shares by the CEO and CFO, which constitutes insider trading or director's dealing. The structure, use of RNS Number, and the final section detailing 'Notification and public disclosure of transactions by persons discharging managerial responsibilities' strongly indicate a regulatory filing related to insider transactions. This aligns perfectly with the definition for Director's Dealing (DIRS). Although it is distributed via RNS, the specific subject matter is Director's Dealing, making DIRS the most precise classification over the general RNS fallback.
2025-06-02 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.